Chinese Medical Sciences Journal ›› 2022, Vol. 37 ›› Issue (3): 240-45.doi: 10.24920/004167
• 一切为了人民健康一一我们这十年: 特别报道 • 上一篇 下一篇
收稿日期:
2022-09-13
接受日期:
2022-09-14
出版日期:
2022-09-30
通讯作者:
王卫,王健伟
E-mail:wangwei@cams.cn;wangjw28@163.com
Taolian Yang1,Hua Zhong2,Wei Wang1,*(),Jianwei Wang3,*()
Received:
2022-09-13
Accepted:
2022-09-14
Published:
2022-09-30
Contact:
Wei Wang,Jianwei Wang
E-mail:wangwei@cams.cn;wangjw28@163.com
摘要:
本文从深化科技体制改革、优化科技创新生态方面重点梳理了中国医学科学院北京协和医学院(以下简称“院校”)在医学健康科技创新发展中的改革举措,初步总结了院校近十年来通过科技创新守卫人民健康、推进健康中国战略的亮点工作,主要展示了其在基础研究、疾病防治、医药技术等领域科技创新成果。这些科技成果的取得凸显了院校为实现医学科技自立自强、全面推进健康中国建设提供重要支撑,为我国医学科技事业发展做出重要贡献。
Taolian Yang, Hua Zhong, Wei Wang, Jianwei Wang. A Decade of Scientific and Technological Innovation at Chinese Academy of Medical Sciences & Peking Union Medical College: Retrospect and Prospect[J].Chinese Medical Sciences Journal, 2022, 37(3): 240-45.
1. | Chinse Academy of Medical Sciences. Science and Technology Evaluation Metrics. News overview. Available from: http://top100.imicams.ac.cn/news. Accessed: September 30, 2022. |
2. |
Wang C, Zhai XM, Zhang XQ, et al. Gene-edited babies: Chinese Academy of Medical Sciences’ response and action. The Lancet 2019; 393(10166): 25-6. doi: 10.1016/S0140-6736(18)33080-0.
doi: 10.1016/S0140-6736(18)33080-0 |
3. |
Chen K, Liu J, Liu SX, et al. Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity. Cell 2017; 170(3): 492-506.e14. doi: 10.1016/j.cell.2017.06.042.
doi: S0092-8674(17)30761-4 pmid: 28753426 |
4. |
Wang P, Xu JF, Wang YJ, et al. An interferon-independent lncRNA promotes viral replication by modulating cellular metabolism. Science 2017; 358(6366):1051-5. doi: 10.1126/science.aao0409.
doi: 10.1126/science.aao0409 pmid: 29074580 |
5. |
Xu XQ, Xu J, Wu JC, et al. Phosphorylation-mediated IFN-γR2 membrane translocation is required to activate macrophage innate response. Cell 2018;175(5):1336-51.e17. doi: 10.1016/j.cell.2018.09.011.
doi: S0092-8674(18)31183-8 pmid: 30318148 |
6. |
Jiang MH, Zhang SK, Yang ZH, et al. Self-recognition of an inducible host lncRNA by RIG-I feedback restricts innate immune response. Cell 2018; 173(4): 906-19. doi: 10.1016/j.cell.2018.03.064.
doi: S0092-8674(18)30396-9 pmid: 29706547 |
7. |
Han YM, Liu QY, Hou J, et al. Tumor-induced generation of splenic erythroblast-like Ter-Cells promotes tumor progression. Cell 2018; 173(3):634-48.e12. doi: 10.1016/j.cell.2018.02.061.
doi: S0092-8674(18)30238-1 pmid: 29606356 |
8. |
Shen QC, Zhang Q, Shi Y, et al. Tet 2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation. Nature 2018; 554(7690):123-7. doi: 10.1038/nature25434.
doi: 10.1038/nature25434 |
9. |
Liu Y, You YL, Lu ZK, et al. N6-methyladenosine RNA modification-mediated cellular metabolism rewiring inhibits viral replication. Science 2019; 365(6458):1171-6. doi: 10.1126/science.aax4468.
doi: 10.1126/science.aax4468 pmid: 31439758 |
10. |
Wang L, Wen MY, Cao XT. Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses. Science 2019; 365(6454):eaav075. doi: 10.1126/science.aav0758.
doi: 10.1126/science.aav0758 |
11. |
Liu YY, Liang XY, Dong WQ, et al. Tumor-repopulating cells induce PD-1 expression in CD8+ T Cells by transferring kynurenine and AhR activation. Cancer Cell 2018; 33(3):480-94.e7. doi: 10.1016/j.ccell.2018.02.005.
doi: 10.1016/j.ccell.2018.02.005 |
12. |
Liu YY, Fang YL, Chen XF, et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci Immunol 2020; 5(43):1-13. doi: 10.1126/sciimmunol.aax7969.
doi: 10.1126/sciimmunol.aax7969 |
13. |
Zhou J, Xu JY, Zhang LL, et al. Combined single-cell profiling of lncRNAs and functional screening reveals that H 19 is pivotal for embryonic hematopoietic stem cell development. Cell Stem Cell 2019; 24(2):285-98. doi: 10.1016/j.stem.2018.11.023.
doi: S1934-5909(18)30559-9 pmid: 30639035 |
14. |
Dong F, Hao S, Zhang S, et al. Differentiation of transplanted haematopoietic stem cells tracked by single-cell transcriptomic analysis. Nature Cell Biol 2020; 22(6):630-9. doi: 10.1038/s41556-020-0512-1.
doi: 10.1038/s41556-020-0512-1 |
15. |
Wang FJ, He JH, Liu SQ, et al. Comprehensive RNA editome reveals that edited Azin 1 partners with DDX1 to enable hematopoietic stem cell differentiation. Blood 2021; 138(20):1939-52. doi: 10.1182/blood.2021011314.
doi: 10.1182/blood.2021011314 |
16. |
Li RY, Di L, Li J, et al. A body map of somatic mutagenesis in morphologically normal human tissues. Nature 2021; 597(7876):398-403. doi: 10.1038/s41586-021-03836-1.
doi: 10.1038/s41586-021-03836-1 |
17. |
Yang XL, Li JX, Hu DS, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (Prediction for ASCVD Risk in China). Circulation 2016; 134(19):1430-40. doi: 10.1161/CIRCULATIONAHA.117.027318.
doi: 10.1161/CIRCULATIONAHA.117.027318 pmid: 27682885 |
18. |
Lu XF, Liu ZY, Cui QM, et al. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study. Eur Heart J 2022; 43(18):1702-+. doi: 10.1093/eurheartj/ehac093.
doi: 10.1093/eurheartj/ehac093 pmid: 35195259 |
19. |
Zhang WL, Zhang SY, Deng Y, et al. Trial of intensive blood-pressure control in older patients with hypertension. New Engl J Med 2021; 385(9):1268-79. doi: 10.1056/NEJMoa2111437.
doi: 10.1056/NEJMoa2111437 |
20. |
Huang KY, Liang FC, Yang XL. Long term exposure to ambient fine particulate matter and incidence of stroke BMJ: Bri Med J 2020; 368(8229):59. doi: 10.1136/bmj.16720.
doi: 10.1136/bmj.16720 |
21. |
Xu B, Tu SX, Song L, et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet 2021; 398(10317): 2149-59. doi: 10.1016/S0140-6736(21)02248-0.
doi: 10.1016/S0140-6736(21)02248-0 pmid: 34742368 |
22. |
Xiao D, Chen ZM, Wu SN, et al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study. from a national cross-sectional study. The Lancet Respira Med 2020; 8(11):1081-93. doi: 10.1016/S2213-2600(20)30155-7.
doi: 10.1016/S2213-2600(20)30155-7 |
23. |
Chen WQ, Zheng RS, Baade P, et al. Cancer Statistics in China, 2015. CA: Cancer J Clin 2016; 66(2):115-32. doi: 10.3322/caac.21338.
doi: 10.3322/caac.21338 |
24. |
Zeng HM, Chen WQ, Zheng RS, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. The Lancet Global Health 2018; 6(5):e555-e567. doi: 10.1016/S2214-109X(18)30127-X.
doi: 10.1016/S2214-109X(18)30127-X |
25. |
Chen WQ, Xia CF, Zheng RS, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. The Lancet Global Health 2019; 7(2):e257-e269. doi: 10.1016/S2214-109X(18)30488-1.
doi: 10.1016/S2214-109X(18)30488-1 |
26. |
Zhang JJ, Zhao YQ, Dai Yi, et al. Effectiveness of high-risk human papillomavirus testing for cervical cancer screening in China: a multicenter, open-label, randomized clinical trial. JAMA oncology 2021; 7(2):263-70. doi: 10.1001/jamaoncol.2020.6575.
doi: 10.1001/jamaoncol.2020.6575 pmid: 33377903 |
27. | Ministry of Science and Technology of the People’s Republic of China. 2019 National Science and Technology Progress Award Winning Projects Catalogue. Available from: https://www.most.gov.cn/ztzl/gjkxjsjldh/jldh2019/jldh19jlgg/202001/t20200103_150916.html. Accessed:January 10, 2020. |
28 |
Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet 2013; 381(9882):2024-32. doi: 10.1016/S0140-6736(13)61049-1.
doi: 10.1016/S0140-6736(13)61049-1 |
29. |
Li RC, Liu LD, Mo ZJ, et al. An inactivated enterovirus 71 vaccine in healthy children. New Engl J Med 2014; 370(9):829-37. doi: 10.1056/NEJMoa1303224.
doi: 10.1056/NEJMoa1303224 |
30. |
Xue J, Chong HH, Zhu YM, et al. Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide. Cell 2021; 185(1):131-44. doi: 10.1016/j.cell.2021.11.032.
doi: 10.1016/j.cell.2021.11.032 pmid: 34919814 |
31. | Ministry of Science and Technology of the People’s Republic of China. 2020 National Science and Technology Progress Award Winning Projects Catalogue. Available from: https://www.most.gov.cn/cxfw/kjjlcx/kjjl2020/202111/t20211103_177782.html. Released:November 2, 2021; accessed: September 10, 2022. |
32. | Ministry of Science and Technology of the People’s Republic of China. Catalog of the 2017 National Science and Technology Progress Award Winning Projects. Available from: https://www.most.gov.cn/ztzl/gjkxjsjldh/jldh2017/jldh17jlgg/201801/t20180103_137374.html. Released: January 8, 2018; accessed: September 10, 2022. |
33. |
Ren LL, Wang YM, Wu ZQ, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J 2020; 133(9): 1015-24. doi: 10.1097/CM9.0000000000000722.
doi: 10.1097/CM9.0000000000000722 |
34. |
Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. The Lancet 2020; 395(10223):470-3. doi: 10.1016/S0140-6736(20)30185-9.
doi: 10.1016/S0140-6736(20)30185-9 |
35. |
Pang XH, Ren LL, Wu SS, et al. COVID-19 Field Response Group, COVID-19 Laboratory Testing Group. Cold-chain food contamination as the possible origin of COVID-19 resurgence in Beijing. Natl Sci Rev 2020; 7(12):1861-64. doi: 10.1093/nsr/nwaa264.
doi: 10.1093/nsr/nwaa264 pmid: 34676083 |
36. |
Wang YM, Zhang DY, Du GH, et al. Remdesivir in adults with severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial. The Lancet 2020; 395(10236):1569-78. doi: 10.1016/S0140-6736(20)31022-9.
doi: 10.1016/S0140-6736(20)31022-9 |
37. |
Guo L, Wang G, Wang YM, et al. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study. The Lancet Microbe 2022; 3(5): E348-56. doi: 10.1016/S2666-5247(22)00036-2.
doi: 10.1016/S2666-5247(22)00036-2 |
38. |
Li L, Zhang W, Hu Yu, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA 2020; 324(5): 460-70. doi: 10.1001/jama.2020.10044.
doi: 10.1001/jama.2020.10044 pmid: 32492084 |
39. |
He ZY, Ren LL, Yang JT, et al. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. The Lancet 2021; 397(10279): 1075-84. doi: 10.1016/S0140-6736(21)00238-5.
doi: 10.1016/S0140-6736(21)00238-5 |
40. |
Chen SM, Zhang ZJ, Yang JT, et al. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. The Lancet 2020; 395(10232): 1305-14. doi: 10.1016/S0140-6736(20)30744-3.
doi: 10.1016/S0140-6736(20)30744-3 |
No related articles found! |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||
|
Supervised by National Health Commission of the People's Republic of China
9 Dongdan Santiao, Dongcheng district, Beijing, 100730 China
Tel: 86-10-65105897 Fax:86-10-65133074
E-mail: cmsj@cams.cn www.cmsj.cams.cn
Copyright © 2018 Chinese Academy of Medical Sciences
All right reserved.
京公安备110402430088 京ICP备06002729号-1